MaxPlusTM bi fuse extension set with 2 clear needleless connectors - Product Usage: The needlele...

FDA Device Recall #Z-1995-2021 — Class II — June 9, 2021

Recall Summary

Recall Number Z-1995-2021
Classification Class II — Moderate risk
Date Initiated June 9, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm CAREFUSION
Location San Diego, CA
Product Type Devices
Quantity 100 units

Product Description

MaxPlusTM bi fuse extension set with 2 clear needleless connectors - Product Usage: The needleless connector can be used for direct injection, intermittent infusion, continuous infusion, or aspiration.

Reason for Recall

A portion of a validation lot was inadvertently released to the US Market. The product did not meet the validation testing criteria regarding leakage.

Distribution Pattern

U.S.: TN O.U.S.: None

Lot / Code Information

Catalog Number:MP9246-C GTIN: 10885403237157 Lot Number: 20087194

Other Recalls from CAREFUSION

Recall # Classification Product Date
Z-1756-2022 Class II BD MaxGuard Drop Administration set with 3 Need... Aug 1, 2022
Z-1760-2022 Class II BD MaxGuard 15 Drop Administration Set with 4 N... Aug 1, 2022
Z-1754-2022 Class II BD MaxGuard Flow Controller Extension Set with ... Aug 1, 2022
Z-1755-2022 Class II BD MaxGuard Flow Controller Extension Set with ... Aug 1, 2022
Z-1753-2022 Class II BD MaxGuard Extension Set, REF: ME1069 Aug 1, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.